Sabra Healthcare REIT, Inc. $SBRA Position Reduced by Bank of New York Mellon Corp

Bank of New York Mellon Corp trimmed its position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 1.1% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 3,301,139 shares of the real estate investment trust’s stock after selling 38,106 shares during the period. Bank of New York Mellon Corp owned approximately 1.31% of Sabra Healthcare REIT worth $63,481,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in SBRA. Rothschild Investment LLC raised its stake in shares of Sabra Healthcare REIT by 164.6% in the 4th quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock worth $27,000 after buying an additional 889 shares in the last quarter. Smartleaf Asset Management LLC raised its position in Sabra Healthcare REIT by 97.7% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock worth $27,000 after acquiring an additional 714 shares in the last quarter. Strengthening Families & Communities LLC acquired a new stake in Sabra Healthcare REIT in the 4th quarter valued at about $29,000. Danske Bank A S acquired a new stake in Sabra Healthcare REIT in the 3rd quarter valued at about $30,000. Finally, Larson Financial Group LLC boosted its position in shares of Sabra Healthcare REIT by 42.3% during the 3rd quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock valued at $35,000 after purchasing an additional 553 shares in the last quarter. 99.40% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the stock. Scotiabank lowered their price objective on shares of Sabra Healthcare REIT from $22.00 to $19.00 and set a “sector perform” rating on the stock in a research note on Thursday, June 18th. Weiss Ratings lowered shares of Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (b)” rating in a research note on Thursday, June 4th. Cantor Fitzgerald raised their target price on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “neutral” rating in a report on Monday, May 11th. Citigroup restated a “market outperform” rating on shares of Sabra Healthcare REIT in a research report on Wednesday. Finally, Wells Fargo & Company increased their price objective on Sabra Healthcare REIT from $22.00 to $23.00 and gave the company an “overweight” rating in a research report on Monday, June 1st. Eight equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $22.25.

Sabra Healthcare REIT Price Performance

NASDAQ SBRA opened at $21.98 on Thursday. The stock’s 50-day moving average price is $19.63 and its two-hundred day moving average price is $19.80. The company has a current ratio of 4.72, a quick ratio of 4.72 and a debt-to-equity ratio of 0.96. The company has a market cap of $5.54 billion, a PE ratio of 34.89, a PEG ratio of 1.64 and a beta of 0.65. Sabra Healthcare REIT, Inc. has a 1 year low of $17.17 and a 1 year high of $22.55.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 EPS for the quarter, hitting the consensus estimate of $0.16. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. The company had revenue of $211.74 million during the quarter, compared to analysts’ expectations of $209.20 million. During the same period last year, the company posted $0.37 earnings per share. The business’s revenue for the quarter was up 20.9% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. On average, analysts predict that Sabra Healthcare REIT, Inc. will post 1.5 EPS for the current year.

Sabra Healthcare REIT Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, May 29th. Stockholders of record on Friday, May 15th were given a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 5.5%. The ex-dividend date of this dividend was Friday, May 15th. Sabra Healthcare REIT’s dividend payout ratio (DPR) is 190.48%.

Key Headlines Impacting Sabra Healthcare REIT

Here are the key news stories impacting Sabra Healthcare REIT this week:

• Positive Sentiment: Truist Financial raised its price target on Sabra Healthcare REIT from $22 to $24 and reiterated a buy rating, signaling confidence in further upside. Benzinga
• Positive Sentiment: Citizens JMP lifted its price target from $23 to $25 and maintained a market outperform rating, suggesting analysts see additional room for the stock to climb. Benzinga
• Positive Sentiment: Sabra increased FY 2026 EPS guidance to $1.53-$1.55, above the consensus estimate of $1.50, which supports the case for stronger-than-expected earnings. Business Wire
• Positive Sentiment: The company announced a major portfolio reshaping, including plans to re-tenant properties previously leased to Avamere, which may improve occupancy stability and operational quality over time. TipRanks
• Neutral Sentiment: Zacks noted SBRA was a strong recent mover on heavy volume, but also warned that recent FFO estimate revisions could limit near-term follow-through. Zacks

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.